Activation of the NLRP3 inflammasome has been implicated in insulin resistance and associated diseases, such as Alzheimer’s disease, obesity, and cardiovascular disease [32,33,34]. Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.